Gerbitz K D, Boenke B, Paprotta A, Chemnitz U, Hübner G
Institut für Klinische Chemie und Forschergruppe Diabetes, Städt, Krankenhaus München-Schwabing.
J Clin Chem Clin Biochem. 1988 Nov;26(11):659-66. doi: 10.1515/cclm.1988.26.11.659.
Nesidioblastosis pancreas was used as an immunogen in BALB/c-mice to generate monoclonal antibodies against structures of human islet cells. Seven clones were selected by screening 311 growing hybridomas for reactivity with the rat insulinoma cell line, RIN m5F, and with cryostat sections from human pancreas. None of the selected clones reacted with pancreatic hormones or endocrine-specific peptides. Monoclonal antibodies cross-reacting with the RIN-cell line also bound to different endocrine organs or cell lines, while some RIN-cell-negative clones bound only to Langerhans islets from human pancreas.
将胰岛细胞增殖症胰腺用作BALB/c小鼠的免疫原,以产生针对人胰岛细胞结构的单克隆抗体。通过筛选311个生长的杂交瘤与大鼠胰岛素瘤细胞系RIN m5F以及人胰腺冰冻切片的反应性,选择了7个克隆。所选克隆均不与胰腺激素或内分泌特异性肽发生反应。与RIN细胞系发生交叉反应的单克隆抗体也与不同的内分泌器官或细胞系结合,而一些RIN细胞阴性克隆仅与人胰腺的胰岛结合。